CISO Global, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
CISO$0.17-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||||
|---|---|---|---|---|
| 2026 · 2025 | ||||
| Cash flows from operating activities: | ||||
| Net loss | $(1,588,906) | $(5,379,604) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation - stock options | 293,373 | 850,992 | ||
| Stock-based compensation - stock issued for services | - | 7,460 | ||
| Non-cash interest expense | - | 7,898,323 | ||
| Depreciation and amortization | 237,996 | 312,224 | ||
| Non-cash operating lease costs | 41,707 | 41,707 | ||
| Bad debt (recovery) expense | (1,693) | 59,022 | ||
| Change in fair value of derivative liability | - | (5,387,691) | ||
| Loss on extinguishment of convertible notes | - | 839,151 | ||
| Other | 1,031 | 1,750 | ||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | (118,778) | 36,789 | ||
| Contract assets | (38,933) | (32) | ||
| Prepaid expenses and other assets | 71,866 | (738,475) | ||
| Accounts payable | 498,604 | (1,270,975) | ||
| Accrued expenses and other current liabilities | (93,036) | (63,054) | ||
| Lease liabilities | (42,343) | (36,349) | ||
| Deferred revenue | (140,704) | (124,746) | ||
| Net cash used in operating activities | (879,816) | (2,953,508) | ||
| Cash flows from investing activities: | ||||
| Purchases of property and equipment | (8,911) | - | ||
| Net cash used in investing activities | (8,911) | - | ||
| Cash flows from financing activities: | ||||
| Proceeds from sales of common stock, net of offering costs | - | 1,719,556 | ||
| Proceeds from convertible notes payable | - | 5,000,000 | ||
| Proceeds from line of credit | 6,019,500 | 1,000,000 | ||
| Payments on line of credit | (6,182,179) | (923,851) | ||
| Payments on loans payable | (4,513) | (1,639,284) | ||
| Payments of debt issuance costs | - | (1,408,642) | ||
| Net cash (used in) provided by financing activities | (167,192) | 3,747,779 | ||
| Net (decrease) increase in cash and cash equivalents | (1,055,919) | 794,271 | ||
| Cash and cash equivalents - beginning of the period | 1,695,994 | 992,589 | ||
| Cash and cash equivalents - end of the period | $640,075 | $1,786,860 | ||
| Supplemental cash flow information: | ||||
| Cash paid for: | ||||
| Interest | $125,898 | $251,835 | ||
| Income taxes | $ | - | $ | - |
| Supplemental disclosures of non-cash investing and financing activities: | ||||
| Common stock issued in exchange for services | $ | - | $91,000 | |
| Conversion of convertible notes - common stock | $ | - | $7,705,000 | |
| Conversion of Series B Preferred Stock to common stock | $290,880 | $ | - | |
| Adjustment to redemption value of Series B Preferred Stock | $14,200 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.